Table 2. Quality of included studies.
| Author | Primary endotherapy modality |
Multi center vs single center |
Sample size |
GI pathologist |
Total follow-up |
Follow-up person- years vs mean years |
Attrition rate |
Definition of CRIM |
GEJ biopsy sample |
EMR before ablation |
Histology of recurrent BE |
Total quality score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shue et al15 | RFA | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 2 |
|
| ||||||||||||
| Akiyama J et al27 | RFA | 0 | .5 | 0 | 0 | .5 | 1 | 0 | 0 | 0 | 0 | 2 |
|
| ||||||||||||
| Phoa et al49 | RFA | 1 | 1 | 1 | 0 | .5 | 1 | .5 | 1 | 1 | 1 | 8 |
|
| ||||||||||||
| Cotton et al32 | RFA | 0 | 1 | 1 | 0 | .5 | 1 | .5 | 1 | 1 | 1 | 7 |
|
| ||||||||||||
| Strauss et al53 | RFA | 0 | 0 | 1 | 0 | .5 | 1 | .5 | 0 | 1 | 0 | 4 |
|
| ||||||||||||
| Wolf et al54 | RFA | 1 | 1 | 1 | .5 | 1 | .5 | .5 | 0 | 1 | 1 | 7.5 |
|
| ||||||||||||
| Pasricha et al47 | RFA | 1 | 1 | 1 | 0 | 1 | 0 | .5 | 0 | 1 | 1 | 6.5 |
|
| ||||||||||||
| Blevins et al18 | RFA | 1 | 1 | 1 | 0 | .5 | 1 | 1 | 1 | 1 | 1 | 8.5 |
|
| ||||||||||||
| Haidry et al40 | RFA | 0 | 1 | 0 | 1 | .5 | 1 | .5 | 0 | 1 | 0 | 5 |
|
| ||||||||||||
| Johnson et al41 | RFA | 1 | 0 | 0 | 0 | .5 | 1 | .5 | 0 | 1 | 0 | 4 |
|
| ||||||||||||
| Orman et al8 | RFA | 0 | 1 | 1 | 0 | 1 | .5 | .5 | 1 | 1 | 1 | 7 |
|
| ||||||||||||
| Gupta M et al12 | RFA | 1 | 1 | 1 | 0 | .5 | 1 | 1 | 1 | 1 | 1 | 8.5 |
|
| ||||||||||||
| Dulai et al (ULSB)22 | RFA | 0 | 0 | 0 | 0 | .5 | 1 | .5 | 0 | 1 | 1 | 4 |
|
| ||||||||||||
| Dulai et al (LSB)22 | RFA | 0 | 0 | 0 | 0 | .5 | 1 | .5 | 0 | 1 | 1 | 4 |
|
| ||||||||||||
| Choi et al30 | RFA | 0 | .5 | 0 | 0 | .5 | 0 | .5 | 0 | 1 | 1 | 3.5 |
|
| ||||||||||||
| Gupta N et al12 | RFA | 1 | 1 | 1 | 0 | .5 | 1 | .5 | 0 | 1 | 1 | 7 |
|
| ||||||||||||
| Korst et al43 | RFA | 0 | .5 | 0 | 0 | 0 | 1 | .5 | 1 | 1 | 1 | 5 |
|
| ||||||||||||
| Cameron et al29 | RFA | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 4 |
|
| ||||||||||||
| Vacarro et al14 | RFA | 0 | 0 | 0 | 0 | 0 | 1 | .5 | 1 | 1 | 1 | 4.5 |
|
| ||||||||||||
| van Vilsteren et al21 | RFA | 1 | 0 | 1 | 0 | 0 | 1 | .5 | 1 | 1 | 0 | 5.5 |
|
| ||||||||||||
| Pouw et al50 | RFA | 1 | 0 | 1 | 0 | 0 | 1 | .5 | 1 | 1 | 0 | 5.5 |
|
| ||||||||||||
| Chandra et al19 | PDT | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 5 |
|
| ||||||||||||
| May et al7 | PDT | 0 | 1 | 0 | 0 | .5 | 1 | .5 | 0 | 1 | 1 | 5 |
|
| ||||||||||||
| Gad et al36 | APC | 0 | .5 | 0 | 0 | .5 | 1 | 0 | 0 | 0 | 0 | 2 |
|
| ||||||||||||
| Ferraris et al34 | APC | 1 | .5 | 0 | .5 | 0 | 1 | .5 | 0 | 0 | 1 | 4.5 |
|
| ||||||||||||
| Mork et al45 | APC | 0 | 0 | 0 | 0 | .5 | 1 | 0 | 0 | 0 | 1 | 2.5 |
|
| ||||||||||||
| Pedrazzani et al48 | APC | 0 | 0 | 0 | 0 | .5 | 1 | 0 | 1 | 0 | 1 | 3.5 |
|
| ||||||||||||
| Pagani et al46 | APC | 0 | .5 | 0 | 0 | .5 | .5 | 0 | 0 | 0 | 1 | 2.5 |
|
| ||||||||||||
| Familiari et al33 | APC | 0 | 0 | 0 | .5 | 0 | 1 | .5 | 0 | 0 | 0 | 2 |
|
| ||||||||||||
| Schulz et al52 | APC | 0 | .5 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1.5 |
|
| ||||||||||||
| Goldberg et al38 | Cryotherapy | 0 | 0 | 0 | .5 | .5 | 1 | 0 | 1 | 0 | 0 | 3 |
|
| ||||||||||||
| Allison et al39 | MPEC | 0 | 1 | 0 | 1 | .5 | 1 | 0 | 0 | 0 | 1 | 4.5 |
|
| ||||||||||||
| Madisch et al13 | MPEC | 0 | .5 | 0 | .5 | 1 | 1 | .5 | 1 | 0 | 1 | 5.5 |
|
| ||||||||||||
| Fisher et al35 | YAG | 0 | 0 | 1 | 0 | .5 | 1 | .5 | 0 | 0 | 1 | 4.0 |
|
| ||||||||||||
| Konda et al42 | EMR | 1 | 1 | 1 | 0 | .5 | 1 | .5 | 1 | 1 | 1 | 8 |
|
| ||||||||||||
| Conio et al31 | EMR | 1 | 0 | 1 | 0 | 0 | 1 | .5 | 1 | 1 | 1 | 6.5 |
|
| ||||||||||||
| Gorospe et al20 | EMR | 0 | 0 | 1 | 0 | .5 | 1 | 1 | 1 | 1 | 0 | 5.5 |
|
| ||||||||||||
| van Vilsteren et al21 | EMR | 1 | 0 | 1 | 0 | 0 | 1 | .5 | 1 | 1 | 0 | 5.5 |
|
| ||||||||||||
| Gerke et al37 | EMR | 1 | 0 | 1 | 0 | .5 | 1 | .5 | 1 | 1 | 1 | 7 |
|
| ||||||||||||
| Pouw et al50 | EMR | 0 | 1 | 1 | 0 | .5 | 1 | 0 | 1 | 1 | 1 | 6.5 |
|
| ||||||||||||
| Larghi et al44 | EMR | 0 | 0 | 1 | 0 | 0 | 1 | .5 | 1 | 1 | 1 | 5.5 |
MPEC, Multipolar electrocoagulation; RFA, radiofrequency ablation; CRIM, complete remission of intestinal metaplasia; GEJ, gastroesophageal junction; EMR, endoscopic mucosal resection; BE, Barrett's esophagus; PDT, photodynamic therapy; APC, argon plasma; coagulation.